| This Week’s News | Etrasimod, an oral medication developed to treat certain inflammatory conditions, was at the center of Pfizer’s acquisition, but some key cardiovascular assets were also part of the transaction. Etrasimod, an oral medication developed to treat certain inflammatory conditions, was at the center of Pfizer’s acquisition, but some key cardiovascular assets were also part of the transaction. | | |
| Cardiothoracic surgeon Igor Mokryk, MD, spent last week taking his family to the Polish border. This week, he treated his first gunshot wound patient at the Heart Institute in Kyiv. Cardiothoracic surgeon Igor Mokryk, MD, spent last week taking his family to the Polish border. This week, he treated his first gunshot wound patient at the Heart Institute in Kyiv. | | |
| A significant number of cardiologists are mistreated—often in more ways than one—after they tell their employer they are pregnant. A significant number of cardiologists are mistreated—often in more ways than one—after they tell their employer they are pregnant. | | |
| Overall, researchers found, 30-day readmission was less common when heart failure patients used telehealth to check in with a physician after discharge. Overall, researchers found, 30-day readmission was less common when heart failure patients used telehealth to check in with a physician after discharge. | | |
| The European Heart Rhythm Association's annual conference is headed to Denmark. The European Heart Rhythm Association's annual conference is headed to Denmark. | | |
| “These results provide reassuring data that may encourage patients with a history of myocarditis to get vaccinated against SARS-CoV-2,” one specialist said. “These results provide reassuring data that may encourage patients with a history of myocarditis to get vaccinated against SARS-CoV-2,” one specialist said. | | |
| The new consensus document provides a framework for understanding, evaluating, and managing some of the key cardiovascular sequelae of COVID-19 The new consensus document provides a framework for understanding, evaluating, and managing some of the key cardiovascular sequelae of COVID-19 | | |
| "We are staying strong," one surgeon told Cardiovascular Business. "We are staying strong," one surgeon told Cardiovascular Business. | | |
| Telecardiology saw a major boost during the COVID-19 pandemic. Many health systems now want to keep it as a permanent treatment option. Telecardiology saw a major boost during the COVID-19 pandemic. Many health systems now want to keep it as a permanent treatment option. | | |
| Researchers examined data from more than 208,000 patients, sharing their findings in JACC: CardioOncology. Researchers examined data from more than 208,000 patients, sharing their findings in JACC: CardioOncology. | | |
| |
|
| ![]() | |
|